Showing results (891-900 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|May 13, 2026
Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)Rachel E Sanborn, Shawn M Jensen, Christopher Paustian, et al.
Oncoimmunology|June 2, 2026
Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancerAko Azimi, Amirhossein Rahmati, Shima Shahbaz, et al.
Oncoimmunology|January 23, 2015
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cellsJun Yan, Goetz Kloecker, Chris Fleming, et al.
Oncoimmunology|July 3, 2015
NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularizationFusanori Yotsumoto, Weon-Kyoo You, Pilar Cejudo-Martin, et al.
Oncoimmunology|March 27, 2023
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancerVincent Carbonnier, Julie Le Naour, Thomas Bachelot, et al.
Oncoimmunology|July 8, 2026
Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphomaLorenzo Falchi, Martin Hutchings, David Tybor, et al.
Oncoimmunology|June 25, 2026
Sequential axitinib and survivin vaccination unlock curative PD-1 immunotherapy in renal carcinomaFanny Méjean, Thi Tran, Maya Merabet, et al.
Oncoimmunology|March 3, 2020
Metabolism in the tumor microenvironment: insights from single-cell analysisZhengtao Xiao, Jason W Locasale, Ziwei Dai
Oncoimmunology|August 13, 2026
HLA-G functions as a tumor-intrinsic driver of growth and survival in renal cell carcinomaAshwin Ajith, Aparna Geetha Jayaprasad, Useong Chang, et al.
Oncoimmunology|August 27, 2026
Dark matter matters: from noncoding RNA regulation to cancer immunityMaria Lteif, Assia Hijazi, Erwan Morgand, et al.
Pageof 379